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Introduction {#sec1}
============

We are rapidly losing options to treat bacterial infections. This is due primarily to pathogens evolving resistance to antibiotics. For example, some strains of *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Klebsiella pneumoniae* have evolved resistance to all known antimicrobial drugs ([@bib123]). This resistance has dire consequences such as drug-resistant tuberculosis leading to over 200,000 deaths globally per year with more than 2,000 deaths caused by extensively drug-resistant tuberculosis (XDR-TB; [@bib140]). Overall, multidrug-resistant bacterial pathogens cause at least 700,000 deaths globally per year. Deaths due to drug-resistance are projected to increase to 10 million globally per year by 2050 ([@bib97], [@bib61]).

Antimicrobial resistance commonly occurs in hospitals, communities where people live, and agricultural settings. In farms, industrial agriculture, and aquaculture, the misuse and overuse of antibiotics is selecting for antibiotic-resistant bacteria in both animal and plant hosts ([@bib130]). For instance, antibiotics used in industrial agriculture are not typically used to treat bacterial infections but to promote faster growth of animals. This "antibiotic misuse" promotes the evolution of drug-resistant bacteria ([@bib129]). Furthermore, small doses of antibiotics are being released into the environment---through rivers, lakes, soils---in the form of urine, feces, manure, and pharmaceuticals waste. These sublethal doses only reduce bacterial growth compared with growth in the absence of antibiotics ([@bib3]), whereas higher concentrations of antibiotics either completely arrest growth or kill bacteria.

Bacteria have evolved three primary mechanisms to survive and grow in the presence of antibiotics ([@bib18], [@bib7]). First, a population can transiently survive antibiotics through physiological changes that slow down growth---a phenomenon known as **tolerance** ([@bib56], [@bib65]). By comparison, **persistence** is when only a subpopulation of cells is in a slowly growing or non-growing state that is able to transiently survive antibiotics ([@bib8], [@bib133]). Finally, bacteria can evolve genetic modifications that make them survive higher concentrations of antibiotics for longer periods, resulting in **resistance**. Environmental factors such as temperature, pH, and nutrient availability modulate these mechanisms and thus the survival chances of bacteria in the presence of antibiotics.

In recent years it has become evident that temperature plays a key role in cellular, physiological, ecological, and evolutionary processes that affect the survival of bacteria. In this review we synthesize recent studies of antibiotic-temperature links, dissecting them by three types of responses: physiological, genetic, and large-scale responses. These responses manifest at different levels of biological organization and at different spatiotemporal scales ([Figure 1](#fig1){ref-type="fig"}). First, we focus on the transient **physiological responses** to temperature that alter cellular behavior and lead to antibiotic tolerance and persistence. Second, we synthesize observations that link thermal stress with the appearance and maintenance of antibiotic resistance mutations in populations (i.e., **genetic responses**). Third, we explore how local and global changes in temperature are associated with increases in antibiotic resistance and its spread (i.e., **large-scale responses**). Overall, we believe this is a critical time to synthesize these observations, especially considering the alarming global rises in both temperature and antibiotic resistance.Figure 1Temperature and Antibiotics Can Affect Bacterial Survival at Three Temporal and Spatial ScalesLeft: Physiological responses to antibiotics and thermal stress (e.g., heat shock response) are local. That is, they occur at a microscale and mostly affect individual cells. Cells may be exposed to antibiotics and stressful temperatures simultaneously or may encounter these stresses sequentially. In either case, these events are typically short (0.5--48 h) and affect cells over their lifetime or possibly a handful of subsequent generations. Center: When antibiotics and/or stressful temperatures persist for days, resistant bacteria (i.e., individuals carrying heritable genetic mutations that confer stress resistance) take over the population, displacing susceptible bacteria. Right: Finally, resistance spreads across communities (i.e., across different species). Local and global temperatures affect processes such as population growth and the spread of pathogens and vectors that modulate the transmission of antibiotic resistance.

Physiological Responses to Temperature and Antibiotic Stressors {#sec1.1}
---------------------------------------------------------------

Temperature fluctuations have been present since the very beginning of life, and substantial changes in temperature are associated with major biological epochs such as ice ages or the existence of giant insects. As such, living organisms have developed mechanisms to deal with the physiological effects of temperature fluctuations to improve their chances of survival. In this section we review the literature that shows that changes in temperature can harm cellular processes in ways similar to harm caused by certain kinds of antibiotics. Moreover, we note evidence that the heat- and cold shock stress responses are elicited in response to antibiotics. These observations suggest that these general physiological stress responses to temperature could be involved in and partly co-opted for the stress responses to antibiotics and the evolution of antibiotic resistance.

### The Heat- and Cold Shock Stress Responses {#sec1.1.1}

Any environmental condition---such as a non-optimal temperature or sublethal concentrations of antibiotics---that reduces the growth of an organism can be considered a stressor. High-temperature damages the cell by causing cellular proteins to unfold and produce aggregates that harm cellular functioning. Living organisms combat these effects through the activation of a highly conserved cellular stress response known as the heat shock response ([@bib75], [@bib111], [@bib143]). The cell first detects increased temperatures through specific sensory biomolecules that can be either nucleic acids (DNA or RNA) or proteins ([@bib118]). The heat shock response then induces increased expression of two main sets of proteins: (1) chaperones to prevent and reverse the aggregation of misfolded proteins and (2) proteases to degrade misfolded protein aggregates. Besides protein misfolding, heat stress also causes increased membrane fluidity and damage to DNA and RNA ([@bib111]). In addition to chaperones, a genome-wide screen for genes essential for growth at high temperature (47°C) in *Escherichia coli* ([@bib92]) found genes involved in energy metabolism, outer membrane stabilization, membrane transport, DNA repair, tRNA modification, translation control, and cell division. In eukaryotes, heat shock also damages the cytoskeleton and intracellular transport mechanisms ([@bib111]).

RNA polymerase and elongation factors, important components of the cellular machinery involved in transcription and translation, have been observed to have decreased stability in *E. coli* after a shift from 30°C to 42°C ([@bib89]). This suggests that gene expression is slowed down during heat stress. The *E. coli* transcription and translation machinery is also regulated at a transcriptional level ([@bib28]): expression of *rpoA* and *tufB* decreases after temperature shifts from 30°C to 42°C. For a milder temperature shift (from 30°C to 38°C), expression of these genes also decreases under fast heating rates (0.6--8°C/min), but not for slow heating (0.4°C/min).

In *E. coli* the main regulator of the heat shock response is the sigma factor σ32, transcribed by the *rpoH* gene ([@bib5]). High heat increases the concentration of free intracellular σ32. In turn, σ32 binds to the RNA polymerase and initiates the transcription of heat shock genes such as numerous global transcriptional regulators and genes involved in maintaining membrane functionality and homeostasis ([@bib54], [@bib95], [@bib126], [@bib143], [@bib144]). Many chaperones, including DnaK, have been shown to participate in the negative regulation of the heat shock response by binding σ32 and preventing it from activating the expression of heat shock genes ([@bib5], [@bib118]). DnaK also binds to unfolded proteins. As such, many other stresses that cause protein unfolding can compete for DnaK, freeing σ32 and activating the heat shock response. Other organisms have different mechanisms to regulate the heat shock response, but its involvement in other stresses---especially those that cause protein misfolding---seems to be a common theme. In fact, the heat shock response has been shown to be involved in responding to stresses as diverse as cadmium in *Drosophila* spp. ([@bib34]), heavy metals in *Oncorhynchus tshawytscha* ([@bib57]), and ethanol in *Zymomonas mobilis* ([@bib86]) and *E. coli* ([@bib30]).

The cold shock response has not been as extensively studied as the heat shock response and seems to be less conserved across organisms ([@bib141]). Under cold stress, DNA and RNA secondary structures are over-stabilized. This leads to a reduced efficiency of transcription and translation due to impaired movement of DNA polymerase and the ribosome, respectively. For instance, exposure of *E. coli* to cold initially stops growth and severely inhibits the synthesis of proteins except those that constitute the cold shock response ([@bib105]). These cold shock proteins mitigate the damaging physiological effects of low temperatures, which include translational block, reduced membrane fluidity, slow protein folding, and increased negative DNA supercoiling ([@bib9], [@bib105], [@bib141]). The cold shock response also modifies the metabolism of the cell to produce the sugar trehalose, which has a protective effect at low temperatures ([@bib63]). Importantly, cold shock proteins have been shown to be involved in responding to various stresses besides low temperature such as oxidative stress ([@bib76]), osmotic shock ([@bib119]), acid stress, and ethanol ([@bib37]).

### Similarity between the Physiological Effects of Antibiotics and Temperature {#sec1.1.2}

Extreme temperatures and antibiotics harm cells through many different pathways and mechanisms of action. Some of the cellular processes damaged by antibiotics overlap with those affected by changes in temperature. For example, aminoglycosides are a class of antibiotics that induce physiological effects in the cell that are qualitatively similar to those of heat stress. Aminoglycosides harm the cell through two main mechanisms: (1) they bind to the ribosome and introduce errors in protein translation, producing aggregates of misfolded proteins, and (2) they inhibit protein synthesis ([@bib53], [@bib108]). Given that aminoglycosides increase misfolded proteins in cells, they also induce the heat shock machinery. Indeed, DnaK and GroEL, chaperones involved in the heat shock response, have been shown to be induced in response to streptomycin (an aminoglycoside) in *A. baumannii* ([@bib25]) and *E. coli* ([@bib35]). Overexpression of both the DnaK/DnaJ/GrpE and GroEL/GroES chaperone systems have a protective effect against sublethal concentrations of gentamicin ([@bib51]). Overexpression of the GroEL/GroES chaperones resulted in both increased survival to gentamicin and rescued cell growth, whereas the DnaK/DnaJ/GrpE chaperones increased survival but did not rescue growth.

Although aminoglycosides provide a compelling example, similarity to temperature-induced damage is by no means an exclusive feature of this antibiotic class. In a study exploring the effects of several antibiotics that bind to the ribosome in *E. coli*, it was observed that the protein expression profiles of bacteria exposed to many non-aminoglycoside protein synthesis inhibitors (macrolides, fusidic acid, and tetracycline) is similar to that induced under cold shock ([@bib131]).

Another line of evidence supporting the similarity between physiological effects caused by antibiotics and temperature stress comes from genetic manipulations in *Staphylococcus aureus*. Notably, deletion of *cspB*---a major cold shock gene---was found to modify antibiotic susceptibility. Specifically, it resulted in increased resistance to aminoglycosides (≈80-fold for gentamicin) and trimethoprim (\>16-fold) as well as increased sensitivity to daptomycin (≈20-fold) and teicoplanin (≈4-fold), as measured by changes in the minimum inhibitory concentration (MIC; [@bib40]).

Finally, similarities between the physiological effects of antibiotics and temperature can be learned from interactions between stressors. Interactions between stressors can be defined in terms of the effect on the growth of the organism when they are present simultaneously. Stressors can interact synergistically, having a greater effect in reducing the growth of an organism than would be expected given the effect of the individual stressors. Alternatively, they can interact antagonistically when the combination of the stressors is less effective than expected, or additively when the effects of the stressors on growth are independent and the combination is as effective as expected. Stressors that harm the same cellular components tend to interact similarly with other stressors when used in combination ([@bib120], [@bib142]). Because of this, drugs and temperatures that induce similar physiological damage to the cell tend to be synergistic or antagonistic to the same set of stressors.

A recent study by some of us measured the interactions (synergy or antagonism) between the effects of twelve antibiotics and six non-optimal growth temperatures on the growth of *E. coli* ([@bib35]). By grouping antibiotics and temperatures with similar interaction profiles, antibiotics were classified into groups with specific growth temperatures based on similar physiological effects in the cell. This provides an expanded look at the relationship between temperature-induced and antibiotic-induced damage to the cell by including previously unexplored antibiotic classes and multiple temperatures that correspond to different levels of heat or cold stress. The similarity to temperature stress of the specific antibiotics evaluated in our study ([@bib35]) is summarized in [Table 1](#tbl1){ref-type="table"} and compared with the results of a previous study that explored the similarity between the protein expression profile induced under temperature stress and various ribosome-targeting antibiotics (macrolides, fusidic acid, tetracycline, and aminoglycosides; [@bib131]).Table 1Classification of Antibiotics by Similarity to Temperature Stress according to the Induced Protein Expression Profile ([@bib131]) or Interactions with Other Stressors ([@bib35]) in *E. coli*Antibiotic Class:\
Antibiotic Tested (Abbreviation)Cellular Process (Effect)Protein Expression SimilarityInteraction SimilarityChloramphenicol:Protein synthesis (inhibition)Cold shockNot measured Chloramphenicol (CHL)Macrolides:Protein synthesis (inhibition)Cold shock (SPR, ERY)Cold (22°C--25°C) (ERY, CLI) Clindamycin (CLI) Erythromycin (ERY) Spiramycin (SPR)Fusidanes:Protein synthesis (inhibition)Cold shockNot measured Fusidic acid (FUS)Tetracyclines:Protein synthesis (inhibition)Cold shockCold (22°C--37°C) Tetracycline (TET)Fluoroquinolones:DNA supercoilingNot measuredCold (22°C--37°C) Ciprofloxacin (CPR) Levofloxacin (LVX)Folic acid synthesis inhibitors:DNA synthesis (Reduction)Not measuredHot (44°C) Trimethoprim (TMP)Nitrofurans:Multiple, including damage to DNANot measuredHot (44°C) Nitrofurantoin (NTR)Aminoglycosides:Protein synthesis (misfolding and aggregation)Heat shock (KAN, STR, PUR)Very hot (46°C)\
(GEN, TOB, STR) Gentamicin (GEN) Kanamycin (KAN) Puromycin (PUR) Streptomycin (STR) Tobramycin (TOB)Beta-lactams:Cell wall synthesisNot measuredNone Ampicillin (AMP) Cefoxitin (FOX)[^1]

#### Antibiotic Classes with Similar Physiological Effects to Heat {#sec1.1.2.1}

Aminoglycosides---gentamicin, tobramycin, and streptomycin---were found to interact similarly in *E. coli* to 46°C, the highest temperature evaluated in [@bib35] ([Table 1](#tbl1){ref-type="table"}). The protein-expression profile induced by kanamycin, streptomycin, and puromycin in *E. coli* has also been found to be similar to that induced under heat shock ([@bib131]). These observations are likely due to the similarity between the effects of temperature-induced protein unfolding and aminoglycoside-induced misfolded proteins due to translational misreading ([@bib67]). The presence of misfolded proteins under aminoglycosides may induce the expression of chaperones involved the heat shock response, as has been shown for DnaK and GroEL in *A. baumannii* ([@bib51]). Overexpression of the heat shock chaperones DnaK and GroEL has also been shown to confer protection against sublethal concentrations of gentamicin in *E. coli* ([@bib51]).

Other antibiotics were also found to have effects similar to heat. In particular, nitrofurantoin and trimethoprim---antibiotics that either damage DNA or prevent its synthesis---were found to have interactions similar to those of a milder heat stress (44°C) in *E. coli* ([Table 1](#tbl1){ref-type="table"}). Interestingly, DNA repair mechanisms have also been linked to heat stress. A genome-wide screen searching for thermotolerant proteins in *E. coli* ([@bib92]) discovered that various proteins involved in DNA repair (*dnaQ*, *holC*, *priA*, *ruvA*, and *ruvC*) are indispensable for growth at 47°C. It has also been reported that Hsp70, a heat shock protein, protects a human-derived cell line from DNA damage ([@bib94]). This raises the possibility that this interaction similarity could perhaps be due to the involvement of DNA-protecting and -repairing enzymes. However, further study is needed to clarify the extent to which DNA damage occurs during high-temperature stress and the mechanistic details of the involvement of DNA-protecting and -repairing enzymes in responding to high-temperature stress and antibiotics. More research is also needed to elucidate if there are any differences between the DNA repair systems involved in responding to heat-similar DNA-damaging antibiotics (nitrofurantoin and trimethoprim) and fluoroquinolones, cold-similar antibiotics that inhibit DNA gyrase (see [Table 1](#tbl1){ref-type="table"} and below).

#### Antibiotic Classes with Similar Physiological Effects to Cold {#sec1.1.2.2}

All the non-aminoglycoside protein synthesis inhibitors studied in [@bib131] and [@bib35] were found to either induce a cold-shock-like protein expression pattern or interact with other stressors in a way similar to cold temperatures in *E. coli* ([Table 1](#tbl1){ref-type="table"}). Since translational block is one of the main effects of cold stress ([@bib141]), it seems possible that the cellular machinery that responds to these antibiotics might overlap with that activated under cold shock. One important qualitative difference exists between macrolides and tetracycline. Tetracycline was found to have similar interactions to cold stress across a wide range of low temperatures (22--37°C), whereas macrolides were found to be similar to a narrower temperature range (22°C--25°C) corresponding to the lowest temperatures evaluated ([@bib35]).

Another class of antibiotics that was found to interact in a similar way as cold temperatures (22°C --37°C) with other stressors in *E. coli* is fluoroquinolones ([Table 1](#tbl1){ref-type="table"}). This class of antibiotics inhibits DNA gyrase, thereby reducing the negative supercoiling of the bacterial chromosome ([@bib1]). Notably, DNA gyrase is induced in the cold shock response, where it has an important role in regulating the supercoiling of the bacterial chromosome ([@bib141]). It seems plausible that some of the cellular machinery that regulates DNA supercoiling could be used for dealing with both stressors, which might account for their similar interaction profiles.

### Sequential Exposure to Antibiotics and Temperature {#sec1.1.3}

Thus far, we have focused on the physiological effects of antibiotic and temperature stress on bacterial cells, both when encountered individually and when combined simultaneously. In this section we explore the implications when they are exposed sequentially. Previous studies have explored the effects of sequential exposure of both different antibiotics ([@bib69], [@bib78], [@bib88]) and antibiotics and temperature ([@bib4], [@bib58], [@bib81], [@bib109]). Even transient exposure to a stressor can modify how an organism responds to subsequent stress. This can result in a primed response to a second stressor (termed the *triggering stressor*), where the organism has better survivability compared with the unprimed response ([@bib58]).

A recent meta-analysis ([@bib4]) evaluated more than thirty studies of sequential exposure to stressors in various microbes, including gram-negative bacteria (*Salmonella typhimurium*, *Vibrio harveyi*, *Vibrio cholerae*, *E. coli*, and *Pseudomonas putida*), gram-positive bacteria (*Listeria monocytogene*s, *Lactobacillus lactis*, and *S. aureus*), and fungi (*Saccharomyces cerevisiae*, *Schizosaccharomyces pombe*, *Candida albicans, Aspergillus nidulans*, *Metarhizium anisopliae*, and *Neurospora crassa*). The authors found that, on average, the survival of microorganisms to a stressor is about 10-fold higher after priming. The stressors evaluated in the individual studies were categorized by the authors into temperature, pH, osmotic, oxidative, growth, and physiological stress (a detailed list can be found in Supplementary Table 3 of [@bib4]). The greatest cross-protection to a second stressor (as measured by increased survival) was found when temperature, osmotic, and physiological stress were the priming stressors.

Antibiotics are sometimes used in sequential exposure and combinations in part to help prevent tolerant bacterial populations. Tolerant bacteria can survive temporary exposure to a stressor by transiently stopping growth but lack the ability to grow or reproduce while exposed to the stressor ([@bib100]). When bacteria are exposed to different stressors sequentially there is the possibility of cross-tolerance arising. This phenomenon occurs when previous exposure to a stressor renders tolerance to a different kind of stress ([@bib138]). Persister cells exhibit multidrug tolerance, which has been proposed to arise through metabolic quiescence by the inactivation of the cellular processes targeted by antibiotics ([@bib73]). However, a more recent study testing cross-tolerance between various antibiotics (ciprofloxacin, ampicillin, and gentamicin) in *E. coli* and *S. saprophycus* has suggested that the mechanisms for tolerance may be shared between antibiotics that target similar processes rather than through generalized cell dormancy ([@bib52], [@bib138]). We expect these shared tolerance mechanisms might also extend to different kinds of stressors (such as temperature, pressure, or pH) when the cellular processes targeted by an antibiotic and the stressor overlap. In general, we hypothesize that cross-tolerance is likely to be stronger in contexts in which the physiological damage to the cell is similar, so that the stress response elements induced by a priming stressor are effective at mitigating the damage by the triggering stressor.

Indeed, pre-exposing cells to temperature, antibiotics, or other stressors has been shown to provide protective effects against subsequent stressful temperature or antibiotics ([@bib4], [@bib58], [@bib109]). [@bib25] offer an example of cross-tolerance involving temperature and antibiotic stress in *A. baumannii*. In this study, bacteria pretreated with high temperature (45°C for 30 min) and then exposed to an even higher temperature (50°C for 15 min) had a greater survival rate (≈80% versus ≈50% in the absence of pretreatment). The cells pretreated with heat shock also had higher rates of survival (≈75% versus ≈50%) when exposed to streptomycin, an aminoglycoside. Consistent with the temperature classification above ([Table 1](#tbl1){ref-type="table"}), the authors suggest that molecular chaperones can play important roles for both thermotolerance and antibiotic tolerance ([@bib25]). Further evidence for the role of chaperones in mitigating aminoglycoside-induced damage is given by a study ([@bib51]) that shows that overexpression of the chaperone GroEL protects against the bactericidal effect of gentamicin in *E. coli*.

However, in contrast to these studies, susceptibility to amikacin (as measured by changes in MIC) was found to increase by at least 4-fold in *E. coli* and *S. enterica* and between 2- and 4-fold in *S. aureus* after incubating at high temperature (45°C) until stationary phase ([@bib84]). Increased susceptibility to amikacin remained even upon the removal of the high temperature. This discrepancy on the protective effect of high-temperature exposure to aminoglycosides across studies may be related to differences in the experimental conditions (for example, short- versus long-term high-temperature exposure or cells in exponential versus stationary phase) or metrics for antibiotic susceptibility (percent survival versus MIC determination). This example highlights that more research on sequential exposure to temperature and antibiotics is needed to fully understand the mechanisms of cross-tolerance.

### Persister Cells {#sec1.1.4}

Antibiotic persistence can occur either spontaneously or can be triggered ([@bib8], [@bib7], [@bib21], [@bib139]). In the first case, a subpopulation of cells randomly switches into the persister phenotype under normal/unstressed growth conditions. In contrast, triggered persister cells form after exposure to a previous stressor and may remain persisters for a substantial amount of time after removal of the stressor ([@bib8], [@bib7]). The exact mechanisms of the persistence response are variable and still up for debate ([@bib71], [@bib87], [@bib107]). However, persister cells have been shown to appear with many different types of stressors, including nutrient limitation in *E.coli, S. aureus,* and *Mycobacterium smegmatis* ([@bib55]); high cell density in *E. coli* ([@bib132]); and exposure to antibiotics in *E. coli* ([@bib38]) and *S. aureus* ([@bib62]).

Although it has not been directly shown that heat shock can lead to persister cells, it is known that heat shock can induce phenotypic heterogeneity ([@bib20]). Bruhn-Olszewska and colleagues showed that two distinct subpopulations form after an *E. coli* culture is exposed to heat shock at 50°C. Upon transfer to LB medium, a high-density subpopulation resumed growth immediately. However, the growth of a low-density subpopulation was considerably postponed. This subpopulation was determined to primarily contain viable but non-culturable cells by quantifying the number of live cells through fluorescence microscopy and comparing with colony-forming unit (CFU) counts. The low-density subpopulation exhibited a higher tolerance (i.e., increased rate of survival) to sublethal concentrations of antibiotics and hydrogen peroxide.

Arguably, this low-density population should be considered persister cells, since it meets all requirements of the definition. That is, it is a slow-growing subpopulation of cells that acquired an enhanced tolerance to all antibiotics tested (ampicillin, kanamycin, rifampicin, trimethoprim, and nalidixic acid). Especially striking results were found for low sublethal concentrations of ampicillin and kanamycin. The low-density fraction exhibited near 100% survival compared with approximately 20% (ampicillin) and 40% (kanamycin) survival for the high-density fraction. Moreover, the acquired tolerance was not greatly correlated to the concentration of the antibiotic ([@bib20]), which is one of the hallmarks of persister cells ([@bib7]). The fact that previous exposure to heat increases tolerance to some antibiotics is further support for similarities between both the physiological effects and the protective responses to antibiotic and temperature stress.

Genetic Adaptations to Temperature and Antibiotic Stressors {#sec1.2}
-----------------------------------------------------------

Previously, we discussed how temperature modifies the susceptibility to antibiotics through changes in growth and related gene expression. These effects are transient, affecting individuals (i.e., plastic changes). Here we discuss temperature effects on long-term heritable effects conferred by genetic modifications that can truly be termed the evolution of antibiotic resistance. Antibiotic resistance can evolve through spontaneous mutations or can be acquired through horizontal gene transfer (e.g., plasmids, bacteriophages). Horizontal gene transfer is an important evolutionary force for spreading resistance, but its relationship with temperature is not well studied (but see [@bib134] showing that horizontal gene transfer is more common at 30°C than at 25°C). Thus, we focus on reviewing spontaneous mutations that confer resistance to antibiotics---antibiotic resistance mutations---and their relationship with temperature. We first focus on how temperature stress selects for *de novo* evolution of antibiotic resistance and then review how it maintains resistance mutations in the population.

### *De Novo* Evolution of Antibiotic Resistance {#sec1.2.1}

The use of antibiotics is the main selective pressure favoring the evolution of antibiotic resistance. For example, in clinics and farms the use of antibiotics selects for antibiotic resistance mutations ([@bib130]). Antibiotic resistance mutations confer the ability to survive high concentrations of antibiotics, and therefore, individuals that carry them have a selective advantage over their susceptible counterparts. Resistant individuals outcompete susceptible ones and, over time, take over the population. But, the use of antibiotics is not the only selective pressure favoring the evolution of antibiotic resistance. Temperature also selects for resistance mutations. As previously discussed, both antibiotics and temperature act on similar cellular functions. Consequently, mutations conferring resistance to temperature stress can confer resistance to antibiotics and *vice versa* ([@bib113]), a phenomenon known as collateral resistance or cross-protection ([@bib39]).

One example of cross-protection was observed during an *in vitro* evolution experiment in which *E.coli* was exposed to high-temperature stress for 2,000 generations ([@bib113]). After hundreds of generations, 12 of 115 experimental lines acquired *de novo* mutations conferring rifampicin resistance, despite the fact that bacteria were never exposed to antibiotics during the evolution experiment. The selective pressure was a high temperature of 42°C, within the range of both temperatures found in humans ([Box 1](#tbox1){ref-type="boxed-text"}) and in soils in the environment. Cross-resistance evolved because temperature and rifampicin acted on the same target of selection---RNA polymerase---that transcribes DNA into RNA and controls gene expression. Mutations in the active site of the RNA polymerase led to changes in gene expression that were adaptive under high-temperature stress ([@bib114]). The same amino acid substitutions that alter gene expression also prevent the binding of rifampicin to the active site of the RNA polymerase. Given that rifampicin could not bind to the RNA polymerase it could not exert its inhibitory action. Therefore, rifampicin resistance evolved as a collateral effect of heat-stress adaptation. Interestingly, some of the high-temperature adapted strains showed increased resistance to two antibiotics (trimethoprim and nitrofurantoin) and increased sensitivity to two other antibiotics (erythromycin and clindamycin; [@bib35]). This resistance pattern was different between *rpoB* single-mutants and high-temperature adapted strains suggesting that additional mutations contributing to thermal stress adaptation contribute to antibiotic resistance besides *rpoB* mutations. Further studies are needed to elucidate the molecular mechanisms underlying the acquired sensitivity and resistance to these antibiotics.Box 1The Case of Fever in Animals and Antibiotic ResistanceWe have reviewed several studies in which stressful high temperatures, ranging between 40°C and 45°C, influence how bacteria respond to antibiotics. In humans, a high fever can occur around 40°C and sometimes body temperature may rise above 41°C (e.g., hyperthermia; [@bib122], [@bib41]). It could be clinically useful to consider how fevers influence antibiotic treatment ([@bib31]).On the one hand, fever could speed evolution of resistance or select for *de novo* antibiotic resistance mutations (e.g., *rpoB* mutations). One caveat for this hypothesis is that fever is transient. After a few hours of fever, body temperature returns to around 37°C, a temperature at which *rpoB* mutations (advantageous at 40°C--42°C) are deleterious. So, even if a fever is long enough for resistance mutations to appear, a "normal" body temperature would purge costly resistance mutations. Nevertheless, a recent study shows that *rpoB* mutations are not necessarily costly at 37°C in physiological conditions similar to the human body ([@bib80]).On the other hand, fever could occur after an antibiotic treatment. Therefore, resistance mutations may appear because of the antibiotic treatment and fever could maintain resistance mutation even after an antibiotic treatment stops. A fever could alleviate the cost of resistance and could provide time for compensatory mutations to appear. We acknowledge our speculations are based on a handful of studies conducted in *E. coli* exposed to one antibiotic (rifampicin). Nevertheless, rifampicin is a clinically relevant antibiotic prescribed to treat *Mycobacterium tuberculosis* infections (i.e., tuberculosis) with treatments extending up to 3, months ([@bib140]). Alarmingly, in 2018 there were half a million new cases of tuberculosis testing positive for rifampicin resistance ([@bib140]). A common mechanism of rifampicin resistance in clinical isolates involves *rpoB* mutations ([@bib46]). Therefore, it is worth considering the potential effects that fever could have on patients with tuberculosis and treated with rifampicin.

Another mechanism for indirectly acquiring antibiotic resistance is to transition from a free-living to a surface-attached lifestyle (i.e., biofilms; [@bib124]). Even if antibiotics can freely penetrate biofilms, many cells inside biofilms are in a dormant state and therefore are protected against bactericidal antibiotics ([@bib125]). In addition, increased temperature may select for increased biofilm formation ([@bib64]). [@bib64] observed that a marine bacterium, *Roseovarius sp*., formed more biofilms than its ancestral form after evolving for 500 generations at a high temperature of 33°C (25°C being its optimal temperature). Increased biofilm formation was caused by mutations in a quorum-sensing regulator, *luxRI*, and a small RNA-binding regulation protein, *hfq*, that modulates changes in gene expression under stress. Interestingly, increased biofilm formation was not an adaptation to thermal stress *per se* but was an adaptation to reduced oxygen availability caused by the increase in temperature. Therefore, temperature increases modify several environmental factors that in turn select for alternative lifestyles (e.g., biofilms). These alternative lifestyles may result in a higher tolerance to antibiotics that might have broader implications for marine bacteria that are experiencing warmer seawater temperatures caused by climate change.

Temperature not only selects for antibiotic resistance mutations but can also increase the likelihood of their appearance in the first place. Temperature can potentiate adaptive evolution by increasing the phenotypic and genotypic variation in a population (i.e., evolvability; [@bib104]). Previously we discussed how temperature may induce phenotypic variation by either inducing persistence or by triggering cellular "memory." In both cases, when exposed to antibiotics some cells have a higher survival compared with cells that were actively growing or were primed with a previous stress. Although these physiological responses are short and transient, they may provide time for an antibiotic resistance mutation to appear and fix in the population ([@bib13]). This phenomenon was previously observed in *E.coli* exposed to ampicillin pulses ([@bib70]). [@bib70] observed that tolerance to ampicillin, conferred by a long lag phase, allowed cells to survive ampicillin until antibiotic resistance mutations spontaneously appeared and fixed in the population. In principle, a similar phenomenon could occur with pulses of heat stress and antibiotics.

Another mechanism potentiating adaptive evolution is to increase the spontaneous mutation rate and, consequently, increase the probability of evolving adaptive mutations. Increased mutagenesis occurs during the heat shock response and the general stress response ([@bib44]). These responses enhance the activity of error-prone DNA polymerases (e.g., Pol IV) and down-regulate error-correcting enzymes (e.g., MutS and MutH). Both the heat shock response and the general stress response can be induced by shifts in temperature ([@bib114], [@bib136], [@bib95]). Thus, temperature may potentiate adaptive evolution by increasing mutagenesis and providing a large mutational supply.

### Interactions between Temperature Effects and Fitness Effects of Antibiotic Resistance Mutations {#sec1.2.2}

After resistance mutations appear, they can either sweep to fixation or be purged from the population. The fate of a mutation depends on its fitness effect in a given environment ([@bib79]). Naturally, resistance mutations are essentially always beneficial in the presence of antibiotics. But when antibiotics are removed, most resistance mutations become deleterious owing to their fitness costs. These costs occur because enzymes that perform essential cellular functions---such as DNA replication, transcription, protein and cell wall synthesis---work sub-optimally when harboring resistance mutations that result in lower growth rate.

Intriguingly, temperature can alleviate these fitness costs while preserving antibiotic resistance. In this way, they serve a similar genetic role as compensatory mutations that can also ameliorate these fitness costs ([@bib2], [@bib66]). A handful of studies have shown that resistance mutations are not necessarily costly or deleterious under conditions of thermal stress with no antibiotic present ([@bib128], [@bib113]). At least five mutations in the RNA polymerase beta subunit (*rpoB*) that confer resistance to rifampicin in *E.coli* are beneficial at a high temperature of 40°C ([@bib128]) and 42°C ([@bib113]). The exact mechanisms underlying this advantage are not fully known, but *rpoB* mutations confer large fitness advantages at 42°C because they reset gene expression patterns from a stressed state toward an unstressed state ([@bib114]).

Antibiotic resistance mutations are not necessarily costly in antibiotic-free environments, especially if these environments are warm ([@bib128], [@bib113]). That said, in some cases antibiotic resistance mutations are more detrimental at high temperatures ([@bib50]). [@bib50] found that three *rpoB* mutations in *P. aeruginosa* are more costly at 42°C than at 37°C. Why resistance mutations are advantageous in some cases and deleterious in others is still poorly understood and a ripe area for future investigation.

Ecological Shifts to Temperature and Antibiotic Stressors {#sec1.3}
---------------------------------------------------------

Up until now, we have primarily discussed how temperature changes affect bacteria at the cellular and genetic level---within a single bacterium and within single populations of bacteria. Now, we expand our discussion to examine the effects of temperature across a larger spatial scale at the global level. Over the last several decades, there has been a growing awareness that climate change is affecting not only humans and other megafauna and flora but also the world\'s microbial organisms. Here we first discuss how changing temperatures impact infectious disease in terms of geographic ranges and intensities, along with global microbial distributions. We also briefly review how changing climate affects the functioning of microbes within ecosystems. Then, we examine the literature on how global changes in temperatures are changing the presence and prevalence of antibiotic resistance. Critically, when we talk about changing temperatures, we mean not only changes in the mean temperature but also changes in the extreme maximum and minimum temperatures as well as changes in the distribution of warmer and cooler days because all of these can impact the types and frequencies of infectious diseases.

### Climate Change Influences Distribution and Incidence of Pathogens {#sec1.3.1}

For humans, one of the most striking and consequential effects of a global change in temperature is the change in the occurrence, intensity, and distribution of infectious diseases ([@bib17], [@bib32], [@bib42], [@bib121]). Numerous reviews in recent years have focused on climate change and its effects on infectious disease (e.g., [@bib12], [@bib19], [@bib23], [@bib29], [@bib59], [@bib74], [@bib72], [@bib135]). Much of the focus has been on the effects of changing climate patterns on the vectors of the disease, rather than the pathogen causing the disease. For example, in the early 1990s an increase in rainfall increased plant growth and in turn caused the rodent population to take off. This led to increased interactions between humans and rodents that resulted in the hantavirus outbreak in the southwestern U.S. states ([@bib60]). The same is true for Lyme disease, where increasing temperatures affect tick phenology and are predicted to cause earlier seasonal outbreaks of Lyme disease ([@bib90], [@bib98], [@bib99]). For malaria, increasing temperature as little as 0.5°C could result in a 30%--100% increase in mosquito abundance ([@bib22], [@bib49], [@bib103], [@bib115]).

More generally, for malaria, dengue fever, Ross River virus, Zika, and other mosquito-borne diseases, increasing temperatures affect mosquito survival, reproduction, and biting rates ([@bib24], [@bib33], [@bib85], [@bib91]). By mechanistically modeling mosquito species, pathogens, and their thermal responses, more nuanced predictions can be made. In particular, differences among tropical and temperate pathogens---with some increasing and some decreasing---can be predicted based on future temperature means and ranges ([@bib91]).

Such studies that include how temperature affects microbial pathogens---as opposed to only their vectors or carriers---are quite rare and only now appearing, even though temperature directly affects pathogens on a global scale. Most studies connecting increasing temperatures to microbes have measured microbial rates of reproduction ([@bib45], [@bib110], [@bib146]) Increasingly, however, there is an interest in understanding large-scale effects of temperature as well. For example, one recent study found that increasing temperatures would likely result in a substantial shift in microbial communities, particularly an increase in the biodiversity of microbes across much of North America and the Tibetan Plateau ([@bib68]). A recent review presented a consensus statement---substantial evidence that climate change is affecting microorganisms---by some of the leading climate change microbiologists in the world ([@bib29]). For example, ocean warming, acidification, and eutrophication result in increases in macroalgae and harm corals and the hundreds of thousands of microbial species associated with corals ([@bib16], [@bib29], [@bib106], [@bib127], [@bib137], [@bib145]).

In turn microorganisms feedback to affect climate change through their ecosystem functioning capabilities, such as sequestering carbon and contributing to greenhouse gas emissions ([@bib6], [@bib11], [@bib10], [@bib14], [@bib15], [@bib29], [@bib43], [@bib101]). Although the mechanisms and details may be different in marine and terrestrial biomes, the overarching conclusion is the same: warming temperatures have and will continue to have effects on the range, distribution, community composition, and physiological and ecosystem functioning of microorganisms ([@bib29], [@bib48]).

### Novel Studies Associating Climate Change with Antibiotic Resistance {#sec1.3.2}

Given that there is substantial research showing how climate change affects the global distribution of bacteria and their physiological functioning, it should not be surprising that climate change will affect antibiotic resistance at the global scale. Yet it has only been in the last couple of years and only in four papers that there are details of how temperature affects the level of antibiotic resistance on a large geographic scale ([@bib77], [@bib82], [@bib102], [@bib27]). These papers are particularly informative because they not only detail how levels of antibiotic resistance have changed with increasing temperature, but also lay out the foundations for how we can make predictions about the spread of antibiotic resistance on a global scale.

In a recent tour de force, [@bib77] set out to examine the relationship between temperature and antibiotic resistance across the entire United States ([@bib77]). They collected temperature data from 1980 to 2010, using minimum and mean temperatures from throughout the country. The researchers quantified percentages of antibiotic-resistant strains by collecting data from hundreds of hospitals and laboratories across 41 states, ultimately ending up with over 1.6 million bacterial pathogens in their dataset. They focused on resistance in three widespread pathogens of concern: gram-negative *E. coli* and *K. pneumoniae* and gram-positive *S. aureus.* MacFadden and colleagues found that, at the population level, for every 10°C increase in minimum temperature there was a significant increase in the percentage of resistant strains (4.2%, 2.2%, and 2.7%, respectively, for the three pathogens they studied). To our knowledge this is the first study that explicitly connects the increase in temperature expected from climate change to increased antibiotic resistance in pathogens.

Based on these empirical findings, statistical extrapolations of these data into the future could provide guidelines for what we should expect in terms of the scope of the problem of antibiotic-resistant pathogens in the future. Furthermore, by combining these and similar data with climate predictions and more evolutionary and physiologically grounded models---that include mutation rates, standing variance, or effective population size and thermal responses---more targeted predictions by region and in time could be made.

An even more recent follow-up study by [@bib82] examined temperature effects of resistance across 28 countries in Europe, from 2000 to 2016 ([@bib82]). Consistent with [@bib77], the researchers found that increases in temperature increased the percentage of antibiotic-resistant bacteria. This study went a step further. The researchers were not only able to correlate warmer temperatures with an increase in overall presence of resistant bacteria but they also found a correlation between warmer temperatures and increased rates of change for levels of the same resistant bacteria. The careful and meticulous measurements across time in this study over the last two decades allowed a temporal analysis of resistance throughout most of Europe. Importantly, the rapid rate of resistance was observed even after controlling for known factors---such as overall antibiotic consumption and human population density---that affect resistance.

This same pattern of increased percentage of both antibiotic-resistant bacteria and antibiotic-resistant genes in warmer temperatures has also been found in a large study of wastewater treatment plants across Europe ([@bib102]). Given that sewage systems are a major point of transfer of human bacteria to the environment, the researchers focused on twelve wastewater treatment systems in seven European countries. By examining the influent and effluent for antibiotic-resistant bacteria and genes, the authors found that temperature is a critical driver of antibiotic resistance as measured by the persistence of resistance and the spread in the environment ([@bib102]). There appear to be numerous ways higher temperatures can affect resistance, including through a faster rate of mutations with potential for resistance, through effects on which bacteria persist and consequently shift community composition, and through the speed of dispersal across spatial scales.

Another recent paper by [@bib27] hypothesized that drug-resistant fungi *Candida auris* emerged as a new human pathogen because of increasing temperatures caused by global climate change ([@bib27]). It has been suggested that mammals have relatively few fungal diseases compared with abundance of fungal species and ones that are pathogenic in ectotherms. This rarity is hypothesized to be because of the "mammalian thermal barrier"---the temperature difference between the ambient environmental temperature at which fungi can survive and the higher internal temperature of mammals. It has been hypothesized that this thermal barrier evolved during the cretaceous period, with fungal diseases serving as a selective agent for mammals ([@bib26]). Thus, mammals that survived were more likely to be resistant to fungal diseases ([@bib26]).

In contrast, many other species that comprise substantial parts of the planet\'s biodiversity and ecosystem services are being devastated by fungal diseases. Specifically, chytrid fungus is estimated to have caused the extinction of hundreds of species and endangered nearly a third of amphibian species globally, making it one of the deadliest pathogens and invasive species in existence. It has been argued that the spread and deadliness of chytrid is linked to climate change and temperature increases, with substantial work still being done to parse out the various contributing factors ([@bib96], [@bib117], [@bib93], [@bib116]).

With increasing temperatures there will likely be an increase in fungal adaptations to heat in general ([@bib47]). Adaptations to warmer environments can already be seen in experimental studies ([@bib36]), studies of culture collections ([@bib112]), and studies comparing fungal growth in cooler rural habitats versus warmer urban habitats ([@bib83]).

*C. auris* likely started out as a plant saprophyte in wetlands. Subsequent changes in environmental temperatures contributed to both increased presence of *C. auris* (via changes in ecological niches of plant hosts) and beneficial mutations that arose owing to greater UV exposure and higher temperatures. Seabirds could have served as an intermediate host between plants and humans, since fungi that can grow at 40°C--42°C can infect avian hosts. Although definitive pathways to the emergence of pathogens are difficult to discern, the arguments set forth are persuasive that *C. auris* could be the first species discovered that has arisen as a human pathogen as a result of warming temperatures ([@bib27]).

Conclusions {#sec1.4}
-----------

In summary, changes in temperatures are likely to lead to thermal adaptation in microbes that experience rises and declines in temperature---either inside a host or in the external environment. These thermal adaptations may have collateral effects such as higher antibiotic resistance. Even if most microbes are not pathogens, the overall community of microbes serves as a reservoir of antibiotic-resistant genes that can be transmitted to pathogens. Therefore, we suggest that it is critical to study the emergence and persistence of antibiotic resistance both in clinically relevant pathogens as well as non-pathogenic environmental bacteria. In covering all the bases above that we think are needed for this, we invoked processes across many biological scales---from genomic to cellular to physiological to ecological---that also correspond to enormous ranges in spatial and temporal scales---from sub-cellular compartments to global dispersion and from nearly immediate response to stimuli to evolutionary times over eons. We also described work that transcends disciplines by bringing together clinical concerns, drug studies, genomics, mathematical theory, physiology, computation, ecology, statistics, evolution, data analysis, biochemistry, protein dynamics, climate predictions, and even thermal physics. Consequently, to fully understand the factors promoting the current and growing antibiotic resistance crisis, we will need a multidisciplinary, multiscale approach that fully captures and considers effects of temperature.
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[^1]: The specific antibiotics from each class evaluated in each study are indicated in parenthesis, except when an antibiotic class was only explored in one study (in which case we mark the other study as "not measured"). The specific temperatures or temperature ranges with similar interaction profiles to the class from [@bib35] are indicated in the right.
